Combination of mechanical atherectomy and drug-eluting balloons for femoropopliteal in-stent restenosis

Journal of Cardiovascular Surgery

Volumn 55, Issue 3, 2014, Pages 347-349

  Beschorner, U ^a   Zeller, T ^a  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Angioplasty, balloon; Atherectomy; Restenosis

Indexed keywords

GELATINASE A; GELATINASE B; PACLITAXEL;

ATHERECTOMY; ATHERECTOMY CATHETER; CELL MIGRATION; CELL PROLIFERATION; CLINICAL STUDY; DRUG ELUTING BALLOON ANGIOPLASTY; ECHOGRAPHY; FEMOROPOPLITEAL IN STENT RESTENOSIS; HUMAN; IN-STENT RESTENOSIS; LEUKOCYTE ACTIVATION; MECHANICAL ATHERECTOMY; METABOLIC SYNDROME X; NEOINTIMA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION;

ANGIOPLASTY, BALLOON; ANIMALS; ATHERECTOMY; CONSTRICTION, PATHOLOGIC; EQUIPMENT DESIGN; FEMORAL ARTERY; HUMANS; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; RECURRENCE; RETREATMENT; STENTS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY;

EID: 84901822533     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 2012;59:16-23.
2. Dick P, Sabeti S, Mlekusch W, Schlager O, Amighi J, Haumer M et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology 2008;248:297-302.
3. Liistro F, Angioli P, Porto I, Ricci L, Ducci K, Grotti S et al. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: The DEBATE-ISR Study. J Endovasc Ther 2014;21:1-8.
4. Stabile E, Virga V, Salemme L, Cioppa A, Ambrosini V, Sorropago G et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol 2012;60:1739-42.
5. Zeller T, Rastan A, Sixt S, Schwarzwalder U, Schwarz T, Frank U et al. Long-term results after direcdonal atherectomy of femoropopliteal lesions. J Am Coll Cardiol 2006;48:1573-8. (Pubitemid 44528188)
6. Shammas NW, Shammas GA, Helou TJ, Voelliger CM, Mrad L, Jerin M. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center. Cardiovasc Revasc Med 2012;13:224-7.
7. Beschorner U LS, Bettinger D, Noory E, Rastan A, Roland M, Zeller T. Treatment of in-stent-restenosis with silverhawk atherctomy: a single center experience. 16th tricountry Congress for Angiology Graz. VASA 42/S842013. p. 21.
8. Zeller T, Krankenberg H, Rastan A, Sixt S, Schmidt A, Tubler T et al. Percutaneous rotational and aspiration atherectomy in infrainguinal peripheral arterial occlusive disease: a multicenter pilot study. J Endovasc Ther 2007;14:357-64. (Pubitemid 47057920)
9. Beschorner U, Krankenberg H, Scheinert D, Sievert H, Tubler T, Sixt S et al. Rotational and aspiration atherectomy for infrainguinal in-stent restenosis. Vasa 2013;42:127-33.
10. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, Coats S et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 1999;85:1179-85. (Pubitemid 30430623)
11. Farooq V, Gogas BD, Serruys PW. Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv 2011;4:195-205.
12. Katsaros KM, Kastl SP, Zorn G, Maurer G, Wojta J, Huber K et al. Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9. JACC Cardiovasc Interv 2010;3:90-7.
13. Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 2004;44:1373-85. (Pubitemid 39303937)
14. Speck U, Scheller B, Abramjuk C, Breitwieser C, Dobberstein J, Boehm M et al. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 2006;240:411-8. (Pubitemid 44098636)
15. Tellez A DR, Mustapha J, Palmieri TE, Gongora CA, Buszman P, Hyon CM et al. Orbital atherectomy enhances the vascular effect of drug coated balloons in a peripheral restenosis model in the familial hypercholesterolemic swine. Paris: euroPCR; 2013.